Assignee
INFLAZOME LTD
IE·20 granted patents·21 pending applications·19 citations·filing 2018–2024
Top patents by PatentIndex Score
41 records- 0191US11981667B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2022·Granted May 14, 2024·1 cites·8 claims
- 0290US11370776B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jun 28, 2022·6 cites·19 claims
- 0383US11465992B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 11, 2022·1 cites·37 claims
- 0483US10973803B2Sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamideINFLAZOME LTD·Filed 2020·Granted Apr 13, 2021·1 cites·32 claims
- 0581US11613542B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 28, 2023·2 cites·32 claims
- 0680US11834433B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 5, 2023·2 cites·19 claims
- 0780US11542255B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jan 3, 2023·2 cites·24 claims
- 0880US11518739B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Dec 6, 2022·2 cites·22 claims
- 0979US11623922B2CompoundsINFLAZOME LTD·Filed 2018·Granted Apr 11, 2023·1 cites·16 claims
- 1079US2025115591A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 1176US11926600B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 12, 2024·1 cites·12 claims
- 1275US2025019355A1CompoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 1364US2021332020A1Phenylsulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 1455US2021163412A1Novel sulfoneurea compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 1555US2021315862A1Sodium Salt Of N-((1,2,3,5,6,7-Hexahydro-S-Indacen-4-Yl) Carbamoyl) -1 -Isopropyl-1 H-Pyrazole-3-SulfonamideINFLAZOME LTD·Filed 2021·Application pending·0 cites
- 1652US12187702B2Sulfonamideurea compoundsINFLAZOME LTD·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 1752US11884645B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jan 30, 2024·0 cites·20 claims
- 1852US2022401414A1Treatment and prevention of a neurodegenerative disorderINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 1952US2022389031A1Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2052US2022395490A1Treatment of arthritisINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2151US12221434B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Feb 11, 2025·0 cites·19 claims
- 2251US2022409586A1Treatment and prevention of neuroinflammation or an inflammatory brain disorderINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2351US2022409585A1Treatment of autoinflammatory disordersINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2450US12168653B2Sulfonamide derivates as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Dec 17, 2024·0 cites·18 claims
- 2550US11530200B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 20, 2022·0 cites·18 claims
- 2650US2022163539A1Nlrp3 inflammasome inhibitionINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 2750US2023121952A1CompoundsINFLAZOME LTD·Filed 2021·Application pending·0 cites
- 2849US11724988B2ProcessesINFLAZOME LTD·Filed 2019·Granted Aug 15, 2023·0 cites·11 claims
- 2948US2022289766A1Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 3047US11905252B2CompoundsINFLAZOME LTD·Filed 2019·Granted Feb 20, 2024·0 cites·22 claims
- 3147US2021147349A1Phenylsulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3246US11773058B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 3, 2023·0 cites·20 claims
- 3346US2022289692A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 3445US2022106289A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3544US12030879B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jul 9, 2024·0 cites·23 claims
- 3643US12012392B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Jun 18, 2024·0 cites·20 claims
- 3743US2020399242A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3842US2022106288A1Novel sulfoneurea compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 3942US2021122739A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 4041US2020361895A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 4139US2021261512A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →